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Introduction
catalase was an iron-containing enzyme because it was Animal catalase (JZC 1.1 1.1.6; H,o,:H,o, oxidom inhibited by cyanide. Evidence that its prosthetic group reductase) is one of the most intensively studied of all Was hematin was provided by Zeile and Hellstr~m in mammalian enzymes. In 18 18 ~h~~~d observed that 1930. The enzyme was first crystallized from beef liver hydrogen peroxide was decomposed by animal tissues by Sumner and in 1937e It has since been with the liberation of gaseous oxygen: ZH,O, + , ZH,O crystallized from liver and erythrocytes of a number of + 0,. Eighty-thee years later, in 1901, L~~~ estab-animal species, including the human. It has also been lished that this effect was due to a specific enzyme which from bacteria. The primary beef he named catalasec 1923, warburg suggested that liver catalase has been established, but the complete sequence of human catalase is not yet known. All of the animal catalases appear to consistof a complex of four ABBmV1"loNs:
'-P-3,4-dih~drox~~hen~1a1anine; subunits. Each subunit has an apparent molecular p1, isoelectric point; AMP, adenosine msnophosphate; ATP, adenosine triphssphate; GTP, guanosine triphosphate; SDS , weight of about 60 000 and contains one ferriprotoporsodium dodecyl sulfate. phyrin (hematin) group. Upon dilution, the tetramer l~~~~~~~d by Canada Health ad Welfare, grant N~. dissociates into dimers and monomers with concomitant 6a-2135- 53 . h e h s t i h k Mati~nd de la SmG et de la Recher-loss of activity. Although the enzymatic reactions of che Medicale'(France), and the Banting Research Foundation. catalase have been intensively studied, the exact mechaCan. J. Biochem. Cell Biol. Downloaded from www.nrcresearchpress.com by University of Toronto on 10/15/15
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nism of catalysis has not been established and its physiological role has remained perplexing. The puzzle is the following. Firstly, catalase has a very high turnover number, decomposing H202 into O2 and H20 at an exceedingly high rate (catalatic activity). This activity is not its only function. In the presence of very low concentrations of H202 M), it will also oxidize electron donors such as ethanol or phenols (peroxidatic activity). Secondly, the level of H202 is regulated physiologically at concentrations of lo-' M. At these H202 concentrations, another enzyme, glutathione peroxidase , is believed to decompose the H202 because it has a higher affinity for H202 than does catalase. Thus it has been argued that the main function of catalase in tissues must be peroxidatic. Finally, in some cells such as the erythrocyte, the concentration of suitable electron-donor substrates for catalase has been estimated to be so low that there have been doubts that even the peroxidatic activity is of any consequence (1) (2) (3) (4) .
Because catalase has two enzymatic functions and the fact that H202 production in different tissues can vary within a wide range, the actual function of catalase may vary from tissue to tissue or from one subcellular compartment to another. Thus it seems logical to conclude that catalase may react either catalatically or peroxidatically depending on the microenvironment of the cell. Cellular reactions leading to the production of H202 and its catalase-mediated destruction are summarized in Fig. 1 .
Tissue distribution and subcellular localization
Catalase is ubiquitously present in aerobic cells containing a cytochrome system. It is missing in most anerobic organisms, but occurs in the radioresistant species Micrococcus radioresistarzs. These observations have prompted speculation about its in vivo role (1) (2) (3) .
Catalase is most abundant in liver, kidney, and erythrocytes and is least abundant in connective tissue. In the liver cell, catalase is mainly located in peroxisomes, but it has also been identified in the endoplasmic reticulum and cytoplasm (1-3). Although it was previously believed that catalase was present in mitochondria, this view has been questioned (5). Catalase-rich peroxisomes have been visualized in myocardium and smooth muscle fibres. In skeletal muscle, however, catalase seems to be associated with the sarcoplasmic reticulum. In muscle it is the aerobic type I fibres which possess catalase; the anerobic fibres contain very little. The highest activity has been found in slow oxidative muscle. In a given muscle type, the catalase activity varies from one region to another (6,7). Catalase in the mature red blood cell has been regarded as cytoplasmic. However, several reports have provided evidence that it is associated with or present in the erythrocyte membrane (8-1 1). In liver cells, catalase is synthesized as a monomer in the endoplasmic reticulum and is rapidly transferred to the peroxisomes where final assembly to the tetramer takes place (12) .
It is currently believed that both catalase and glutathione peroxidase contribute to the breakdown of H202 in vivoand that both enzymes have important functions, their relative contribution being dictated by their subcellular distribution, their localized concentration, and the availability of H202, hydrogen donors, and reduced glutathione. In liver, the subcellular distributions of these two enzymes are strikingly different. Glutathione peroxidase is located mainly in the mitochondria1 matrix and the cytosol, whereas catalase is highest in the peroxisomes. Even though erythrocytes contain no mitochondria, they contain both catalase and glutathione peroxidase, and in these cells glutathione peroxidase is believed to be of major importance in the breakdown of H202. However, the relative contribution of catalase should increase with increasing concentration of H202 (3) (4) (5) .
Hydrogen peroxide is a normal cellular metabolite as well as a potentially reactive form of oxygen which could cause oxidative damage to tissue. It readily permeates biological membranes and is believed to diffuse from one cell compartment to another, into interstitial fluid, and into the circulation. The intertissue and intracellular partitioning of catalase and glutathione peroxidase would appear to provide a dual and complementary defence mechanism against this mobile source of oxidative stress.
The reader is referred to Refs. information about the roles of glutathione peroxidase, as glutathione S-transferase, and superoxide dismutase in hydrogen peroxide metabolism.
Catalytic reactions
Chance was able to resolve the catalase reaction cycle into two distinct steps by the study of spectral changes during catalysis (13, 14) . In the first step, the native ferric hemoprotein (free catalase) reacts with H202 to form the primary complex: a green, spectrally distinct form, called compound I. In the second step, two electrons are transferred from an electron donor to form water and an oxidized product. The electron donor can be either a second molecule of H202 (catalatic mode) or another substance such as methanol, ethanol, or formic acid (peroxidatic mode). With certain other substrates (e.g., phenols), two electrons are not transferred simultaneously. The rate of transfer of the second electron is slow relative to the transfer of the first and results in the steady-state accumulation of a red, one-electron, reduced form of compound I, which is termed compound 11. Compound I1 is spectrally distinct from free catalase and from compound I and is an inactive form of the enzyme. A third catalase-peroxide complex, compound 111, can be identified spectroscopically. This is obtained by treating compound I1 with H202. The formation of compound I11 is reversible and, on standing, compound I1 is slowly reformed (I).
The overall reactions of catalase may be summarized
where AH2 represents a two-electron donor, and
where AH represents a one-electron donor (I 5, 169. In the catalatic mode, AH2 is a second molecule of H2Q2.
Although the catalatic and peroxidatic reactions are in many ways well characterized, neither the mechanism of formation nor the structure of compound I, 11, or 111 are completely understood. Moreover, the exact mechanism of catalysis by catalase has remained elusive. Nevertheless, the splitting of H2Q2 to H 2 0 and O2 may be regarded as a special case of the peroxidatic reaction in which H202 serves both as a substrate and an acceptor. The peroxidatic reaction is the rule in the presence of an acceptable electron donor when the H202 concentration is low or when the substate is an alkyl peroxide. Finally, if a high steady-state level of compound I is generated in low H202 concentration or with alkyl peroxides as substrate in the absence of an electron donor, the spontaneous decomposition of peroxide will predominate, presumably via the oxidation of an internal hydrogen donor in the catalase apoprotein (1, 3, 15-17).
The following scheme by Keilin and Nicholls summarizes the known reactions of catalase (18) where the hydrogen donors have been indicated by Dl to D6: Dl = ascorbate or ferrocyanide; D2 = phenols; D3 = alcohol or formate; D4 = sodium nitrite; D5 = azide or hydroxylamine: D6 = hydrogen peroxide. Catalase from liver will also catalyze the oxidation of NADH and NADPH by H202; this reaction is enhanced by thyroxine, estradiol-17, and various phenol compounds.
The regulation of catalase expression and catalase heterogeneity Catalase expression in mammals is under complex genetic control. Studies in the mouse have revealed that there is only one structural gene for catalase. Mouse catalase is a glycoprotein and five distinct electrophoretic forms differing in sialic acid content are differentially distributed among different tissues and subcellular organelles. The rate of breakdown of catalase in the liver is controlled by a regulator gene that is unlinked to the structural gene. A different regulator gene is believed to control catalase turnover in the erythrocyte (19, 20) . In addition to these complexities, it is now believed that enzymatically active catalase purified from liver may be a proteolytic cleavage product of a larger precursor form (21) . It has been suggested that the cleavable peptide may play a role in the transport of the enzyme across cellular membranes or may occupy a significant niche in the sequence of in vitro degradation.
These studies of catalase in the mouse may serve as a model system for unravelling the complexities of catalase expression in man. The structural gene for human catalase is on chromosome 11, but tissue-specific regulator genes have not yet been mapped. Putative allelic variants of the human structural gene for catalase have been described. The first structural gene mutation reported for human catalase was observed by Takahara for Japanese individuals who exhibited a hereditary deficiency of blood catalase. This rare autosomal recessive disorder was termed acatalasemia (22) . The structural defect leads to a decrease of catalatic activity early in the life of the erythrocyte to about 1% of that in the control. It is now clear that acatalasemia must be considered to be a group of mutations which all lead to a change in the activity level of the normal enzyme. In many but not all instances the deficiency of erythrocyte catalase is combined with a deficiency of tissue catalase. In some cases, the enzyme variant is characterized by poor stability; in others, a catalase variant of low activity is synthesized. Surprisingly, individuals with acatalasemia are not severely affected, perhaps because the deficiency is never complete and seems to be compensated by an increased activity of the glutathioneregenerating system, notably the hexose monophosphate shunt (2, 23-25).
Feinstein and colleagues (26, 27) have described a series of five radiation-induced mutants for erythrocyte catalase in the mouse. One of these is acatalasemia; the other four are hypocatalasemias. Genetic analysis has shown that this group of erythrocyte mutants is controlled by five different alleles at a single locus corresponding to the site of the catalase structural gene. The suggestion has been made that the acatalasemic mutant is a structural mutation that affects the enzymatically active site of the molecule, while not altering the immunospecificity of the protein. Two additional hypocatalasemic mouse mutants have been subsequently described ( 19) . In addition to the human acatalasemic variants, several rare phenotypes of catalase have been identified by electrophoresis in population surveys in North and South America. They have been attributed to the heterozygosity of different mutant alleles (28, 29) .
Distinct from the electrophoretic variation associated with variant structural alleles of human catalase is a heterogeneity which seems to be induced or increased by storage (30) . Morikofer-Zwez et al. have suggested that this heterogeneity is the result of artifactual oxidation of unessential sulfhydryl groups which cause the introduction of net negative charges in the molecule (31). However, Bonaventura et al. have pointed out that the heterogeneity which this group has defined may be distinct from that seen in freshly isolated erythrocytes (32) . One possible source of heterogeneity in freshly prepared tissue extracts or in purified catalase that has been consistently overlooked is the interconvertibility of free catalase and compounds I, 11, and 111. Catalase has been shown to exist in-the form of compound 1 in tissues. As evident from the scheme of Keilin and Nicholls (1 8), these interconversions can be chemically manipulated, and it should be feasible to determine whether or not the electrophoretic mobility or the isoelectric focusing pattern of free catalase differs from that of compound I, 11, or 111.
It is clear from the preceding discussion that the activity of catalase is regulated at several different levels: by the structural gene, by genes which epigenetically modify and (or) regulate the turnover of the catalase protein, and by the interaction of catalase with its substrates. Abnormalities at any of these levels might affect the activity of catalase.
The relation of catalase and the diphenoloxidases
Although the reactivity of catalase with electron donors such as ethanol has been thoroughly studied, there has been little thought about the potential reactivity of animal catalase towards biologically active phenols such as DOPA and epinephrine ( 17) . The ability of catalase to oxidize epinephrine has long been recognized by microbiologists, however, and this property is exploited routinely to identify catalase-positive microorganisms. Can. J. Biochem. Cell Biol. Downloaded from www.nrcresearchpress.com by University of Toronto on 10/15/15
Enzymes which catalyze the oxidation of DOPA to melanin or epinephrine to adrenochrome have been described in a variety of mammalian tissues by many different groups, but the possibility has never been considered that these enzymes may be catalases (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . Because the reaction conditions for studying these enzymes have been so diverse, it is also difficult to say whether or not the catalytic activity in question has been the same in all of the studies. Nevertheless, the activities which have been described do not catalyze the oxidation of tyrosine to melanin and thus appear to be distinct from the enzymes which have been termed "tyrosinases" (43, 44) . Moreover, Inchiosa et al. showed that the epinephrine-oxidizing enzyme in their study was distinctive from cytochrome c oxidase and ceruloplasmin (37).
Demos, Tuil, and colleagues have focused on watersoluble, ~g'+-dependent enzymes which have been called "diphenoloxidases" (39) (40) (41) (42) (45) (46) (47) (48) . Diphenoloxidase activity in cell extracts is revealed at pH 8.7-18 in two ways: (a') spectrophotometr4cally with epinephrine as substrate by following the absorbance increase at 485 nm (i.e., the conversion of epinephrine to adrenochrome which has an absorption maximum at 485 nm); (is') visually, after resolution by gel electrophoresis or isoelectric focusing, by immersion of the gel in the presence of air and light in a solution of DOPA. In the first assay the substrate is first incubated in the presence of air and light for 30 min; upon addition of the enzyme and a catalytic amount of adrenochrome, epinephrine oxidation occurs very rapidly without a lag period. In the latter case, a diffuse deposit of melanin foms over the enzyme bands.
In rabbit, rat, mouse, and chicken, the diphenoloxidases are found in highest concentration in kidney, erythrocytes, and platelets, and their isoelectric focusing pattern is species and tissue specific (45) (46) (47) (48) . In man, diphenoloxidase activity is high in platelets and erythrocytes. Of particular interest is the fact that in erythrocytes, at least, the enzyme activity is membrane associated as well as cytoplasmic and dependent on ~g~~ ions (45) (46) (47) (48) . The isoelectric focusing patterns of human platelet and erythrocyte diphenoloxidase are not identical. The PI'S of the platelet bands are 6.65 and 6.15, whereas the p%'s of the red cell bands are 6.8 and 6.7. Diphenoloxidase activity is inhibited by M KCN (partial), A4 lead acetate (complete), digestion with pronase for 18 min at 3T°C (complete), and heating for 10 min at 65°C (complete) (45, 46) .
Demos began studies of the diphenoloxidases because he felt that an abnormality in catecholamine metabolism might be a cause of the microcirculatory disturbances which ape associated with the progressive muscular dystrophies (49) . His studies have revealed that platelet diphenoloxidase is significantly reduced in patients with all four major forms of progressive muscular dystrophy (Becker and Duchenne types, X-linked recessive; limbgirdle, autosomal recessive; fascioscapulohumeral , autosomal dominant), as well as in many carriers of these disorders (40) . The reduction in platelet diphenoloxidase activity is greatest in the X-linked lethal recessive Duchenne form and is fourfold lower in affected patients than in controls.
I have confirmed Demos' observations that platelet diphenoloxidase is 50% reduced in known carriers of Duchenne muscular dystrophy relative to sex-and age-matched controls (unpublished observations) and have extended Demos' studies of these diphenoloxidase enzymes. While screening a number of catecholaminemetabolizing enzymes for diphenoloxidase activity, crystalline beef liver catalase and catalase purified to 95% homogeneity from human erythrocytes isolated in 1% disodium EDTA were found to have diphenoloxidase activity as assessed by the two assay methods of Demos (41) . Moreover, when the catalases were resolved by isoelectric focusing on polyacrylamide and duplicate sections of the gel were analyzed in parallel, the banding patterns obtained with stains for catalase activity and diphenoloxidase activity were superimposable. The addition of 1.5 mM H202 to the solution for revealing diphenoloxidase activity reduced the necessary staining time from a couple of hours to a few minutes, but did not alter the banding pattern of the enzyme activity. Superimposable isoelectric focusing patterns of catalase activity and diphenoloxidase activity were also observed in freshly prepared extracts of erythrocytes and platelets, although the patterns were not identical in the two tissues. Moreover, antiserum to catalase has been shown to remove both catalase and diphenoloxidase activity from platelet and red cell extracts. These observations have suggested that catalase and diphenoloxidase may be one and the same enzyme (unpublished observations).
Intuitively, there are several possible explanations for the reduced diphenoloxidase activity in the progressive muscular dystrophies, and the abnormalities which Demos has described might well be a secondary effect associated with these disorders (50) . However, the suggestion that diphenoloxidase and catalase might be the same enzyme raises the possibility that different abnormalities in genes which epigenetically modify catalase or which regulate its turnover might be a fundamental problem in these disorders.
Activity of catalase with P-adrenergic agents and a possible analogy with the P-adrenergic hormone receptor Using Demos' gel method for visualizing enzyme activity with the addition of 1.5 mM H202 to the developing stain, I established that purified beef liver Can. J. Biochem. Cell Biol. Downloaded from www.nrcresearchpress.com by University of Toronto on 10/15/15
catalase and purified human red cell catalase oxidized not only DOPA and epinephrine, but isoproterenol, norepinephrine, and propranolal as well. Isoproterenol, norepinephrine, and epinephrine are (3-adrenergic agonists; propranolol is a P-adrenergic antagonist and a commonly used antihypertensive agent. To establish the relative activity of catalase with these substrates, I tested the ability of these substrates to inhibit the catalatic production of O2 from H202 in the Rank oxygen electrode in Tris-citrate buffer (pH 8.7) containing 4 mM MgW . The rationale for this approach is based on the knowledge that, in the presence of low concentrations of H202, suitable electron-donor substrates will partition the catalatic activity of catalase into the peroxidatic mode (formation of compound I1 and subsequent substrate oxidation) with concomitant inhibition of 0 2 production from the H202. In these experiments the concentration of H202 was fixed at 1.5 mM and the concentrations of the second substrates ranged from 0 to 3 X M. L-DOPA and all three agonists were found to inhibit O2 production from H202 in an apparently competitive manner even at concentrations of lw4-lo-'M. Propranolol inhibited O2 production as well, but less effectively than any of the other substrates tested. It also appeared to competitively inhibit the reaction of epinephrine with catalase as judged by the reaction kinetics. The relative affinities for the substrates tested were established to be L-DOPA > isoproterenol > norepinephrine > epinephrine > > > propranolol, the apparent &'s ranging from 0.032 mM for L-DOPA to 1.7 mlW for D,L-propranolol (unpublished observations). The structures of the compounds tested in these experiments are given in Fig. 2 . It has been previously noted that the three open-chain agonists have the ability to oxidatively cyclize (38) .
Although this suggestion must be regarded as preliminary, the finding that catalase will react with P-adrenergic agonists with surprisingly high affinity forces one to wonder if there is an analogy between these in vitro reactions and the reactions of the P-adrenergic hormone receptors with P-adrenergic agonists and antagonists in cells.
Many different cells respond to the catecholamine hormones epinephrine and norepinephrine. One of the ways these hormones exert their effects is by binding to the hormone receptors of these cells. The binding to the hormone receptor results in activation of the catalytic component of adenylate cyclase and the generation of cyclic AMP (5 1). A schematic relationship between the hormone receptor and other components of the adenylate cyclase holoenzyme system is shown in Fig. 3 .
The p-adrenergic hormone receptor has been difficult to characterize, as the properties of isolated receptors are not identical to those in membrane fractions or whole cells (52) . Nevertheless, binding characteristics of the P-adrenergic agonists to these have been defined and it has been established that isoproterenol is a more potent agonist than epinephrine or-norepinephrine (53j. The antagonists, of which an example is propranoloI, bind to the receptor but do not stimulate adenylate cyclase activity and competitively inhibit agonist binding to the receptor. Persistent exposure of cells to P-agonists leads to a decreased responsiveness to subsequent catecholamine stimulation. h4g2+ promotes binding of agonists, but not antagonists, to the receptor (52) . In the frog erythrocyte, the purified hormone receptor has an apparent molecular weight of 58 000 as estimated by SDS-polyacrylamide gel electrophoresis (54, 55) .
From Fig. 2 , it is evident that the agonists and antagonists have side chains that are chemically similar, but that their aromatic components are not. The steric arrangement of functional groups in the agonists has been hypothesized to play an important role in the production of their biological effect. Conformational analysis of various P2-adrenoceptor stimulating agents has suggested that the crucial feature may be the stereochemical arrangement of their two catechol hydroxyls and the hydroxyl and N groups of their alkyl side chains (56) . The reactions of catalase with the P- *In i~itro at alkaline pH in the presence of Mg2+ (unpublished results). The concept that there is a membrane-bound fc)rni of catalase which interacts with p-adrenerpic agents in viva is speculative. However, several reports have suggested that catalase is associated with or present in the erythrocyte membrane (8) (9) (10) (11) . The enzyme diphenoloxidase, which may be related tocatalase. has also been identified in the erythrocyte rnelnbrane (45) (46) (47) (48) .
tor are compared in Table 1 . Attention is drawn to the similarity in size of their basic subunit; their reactivity with isoproterenol , norepinephrine, and epinephrine; the role of propranolol as an inhibitor; and the ability of hIg2+ to promote reactions with the agonists. For interest, the effect of fluoride on the activity of catalase and the adenylate cyclase holoenzyme has also been included.
Although the reactions of catalase with the Padrenergic agents must currently be regarded as an in vitro novelty, this reactivity merits further investigation. Cyclic AMP Because the P-adrenergic agents react with catalase in vitrs and bind to the P-adrenergic hormone receptor in vivo, it is tempting to speculate that the P-adrenergic homone receptor might be a membrane-associated form of catalase. Thus, the steseochemical conformation of the alkyl side chains of P-adrenoceptor stimulating agents might direct their binding to specific sites in the hormone receptor and the electron-donating properties of the two catechol hydroxyls might be essential for theis biological activity.
Certain properties of catalase and the hormone recep-
The hypotheses that catalase and the diphenoloxidases are structurally related and that the P-adrenesgic hormone receptor is a membrane-associated form of catalase can be tested. Even if these putative identities should be disproven, it is nevertheleis essential to determine whether P-adrenergic agents will react with catalase in intact cells at concentrations used to stimulate adenylate cyclase activity. In addition, given that catalase is associated with the plasma membrane in at least some cells, the effect of ethanol, a known catalase substrate, on the activity of adenylate cyclase should not be overlooked. ~x~e r i m e n t a l systems have been devised to measure compound I and 11 formation and catalase inhibition in intact cells and perfused organs (15, 57, 58) . It will clearly be of interest to study the effects of biologically relevant electron donors such as ethanol and the P-adrenergic agents on catalase using intact cells and organs and to correlate the results with effects on the adenylate cyclase holoenzyme system. That such investigations might prove to be rewarding is already implied from the work of Jones hypertensive agent, inhibits the catalatic activity of catalase in isolated hepatocytes owing to the druginduced formation of compound I1 and the presumptive oxidation of a-methyl DOPA via the peroxidatic pathway (15, 59) . Jones et al. have suggested that this reaction of catalase with a-methyl DOPA may contribute to the known toxic side effects which have been associated with the drug (15) . However, it is also possible that the reactivity of catalase with a-methyl DOPA accounts for the antihypertensive effect of the drug.
Conclusions
In 1938, J. B. S. Haldane stated in his contribution to the monograph Perspectives in Biodzemistry: "The cells of the body are very largely autonomous. So far as we know they all make their own enzymes. Catalase is probably just as important as insulin. We do not know what a man, or a rat, without catalase or even with too little catalase, would be like. And since we cannot stop the cells from making catalase . .. we are not likely to know for a considerable time" (2, 68).
Studies of acatalasemia in man and mouse have implied that even a substantial reduction in the catulatic activity of catalase has minor physiological significance. However, the question of whether the acatalasemic mutations also affect the peroxidatic activities of catalase with DOPA or the P-adrenergic agents has not been examined. Because of this gap in our knowledge and because of the possibility that the peroxidatic activity of catalase is physi~logically more significant than its catalatic activity, Haldane's philosophical commentary still applies.
It is clear from the preceding considerations that although catalase may be an old enzyme, it may have some new physiological roles. The evidence that catalase is associated with or possibly present in the plasma membrane of at least some cells and its demonstrated ability to react with biologically significant electron donors such as ethanol, DOPA, a-methyl DOPA, norepinephrine, epinephrine, and propranolol raise many questions for investigation that might have widespread application in the basic science, clinical, and therapeutic fields.
